Catalent Expert Delivers US Pharmacopeia Update At 10th Annual Cool Chain Europe Conference

Catalent Expert Delivers US Pharmacopeia Update at 10th Annual Cool Chain Europe Conference

Date: 01/14/2011

Somerset, NJ, January 14, 2011 – Dr. Mary Foster, Vice President of Quality for Catalent Pharma Solutions and Chair of the USP Packaging, Storage and Distribution Expert Committee, will speak on the latest update to the US Pharmacopeia (USP) guidance on the packaging, distribution and transportation of drug products as well as new USP General Chapters at the 10th Annual Cool Chain Europe conference on January 24-26 at the World Trade Centre in Rotterdam, The Netherlands.

Dr. Foster will provide an update on the USP general chapter <1079>, including the final highlights and decision of what’s in and what’s out; how companies can become involved in working on future USP guidance; and an update on new USP chapter work in areas such as anti-counterfeiting, pedigree and supply chain best practices. The presentation will begin at 9 a.m. on Tuesday, January 25, the second day of the conference, which is dedicated to Regulatory Readiness and Preparedness and includes presentations from the UK’s MHRA, the German BFarm, and the WHO.

“It is important that the pharmaceutical/biotechnology industry, academia, regulatory agencies and other interested parties understand how valued their input is to chapter revision and new chapter writing for the USP. We need experts from around the world to volunteer and help make a positive impact with this work,” said Dr. Foster.

Dr. Foster is a 28-year veteran of the pharmaceutical / biotechnology industry, with specialized expertise in the area of regulatory compliance, regulatory affairs, quality control and quality assurance roles in the manufacturing, packaging, holding and transportation of product encompassing global operations. She has worked for Catalent for 20 years at various sites and in roles of increasing responsibility within the quality and regulatory function. Today, she serves as the Vice President of Quality for Catalent working on global external relationships with worldwide regulatory agencies, pharmacopeias, academia and industry organizations in standards and guidance setting. Dr. Foster is also responsible for the global cGMP education process.

For a follow-up interview with Dr. Foster, please contact Patricia McGee at .

For more information on the 10th Annual Cool Chain Europe conference, please visit .

About Catalent

Headquartered in Somerset, New Jersey, Catalent is a leading provider of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 at 29 facilities worldwide and in fiscal 2010 generated more than $1.7 billion of annual revenue. For more information, visit

more products. better treatments. reliably supplied.™